+1 347 708 0418
The Drug Delivery in Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Drug Delivery in Cancer size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Drug Delivery in Cancer market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Drug Delivery in Cancer market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Market segment by Application, can be divided into
Hospitals & Clinic
Cancer Treatment Centers
Others
Market segment by players, this report covers
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Drug Delivery in Cancer
1.2 Classification of Drug Delivery in Cancer by Type
1.2.1 Overview: Global Drug Delivery in Cancer Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Drug Delivery in Cancer Revenue Market Share by Type in 2020
1.2.3 Liposomes
1.2.4 PEGylated Proteins & Polypeptides
1.2.5 Polymer Nanoparticle
1.2.6 Protein–drug Conjugates
1.2.7 Others
1.3 Global Drug Delivery in Cancer Market by Application
1.3.1 Overview: Global Drug Delivery in Cancer Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Global Drug Delivery in Cancer Market Size & Forecast
1.5 Global Drug Delivery in Cancer Market Size and Forecast by Region
1.5.1 Global Drug Delivery in Cancer Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Drug Delivery in Cancer Market Size by Region, (2016-2021)
1.5.3 North America Drug Delivery in Cancer Market Size and Prospect (2016-2026)
1.5.4 Europe Drug Delivery in Cancer Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Drug Delivery in Cancer Market Size and Prospect (2016-2026)
1.5.6 South America Drug Delivery in Cancer Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Drug Delivery in Cancer Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug Delivery in Cancer Market Drivers
1.6.2 Drug Delivery in Cancer Market Restraints
1.6.3 Drug Delivery in Cancer Trends Analysis
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Drug Delivery in Cancer Product and Solutions
2.1.4 Amgen Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Drug Delivery in Cancer Product and Solutions
2.2.4 Teva Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Teva Recent Developments and Future Plans
2.3 UCB (Union Chimique Belge)
2.3.1 UCB (Union Chimique Belge) Details
2.3.2 UCB (Union Chimique Belge) Major Business
2.3.3 UCB (Union Chimique Belge) Drug Delivery in Cancer Product and Solutions
2.3.4 UCB (Union Chimique Belge) Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 UCB (Union Chimique Belge) Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Drug Delivery in Cancer Product and Solutions
2.4.4 Roche Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business
2.5.3 Celgene Drug Delivery in Cancer Product and Solutions
2.5.4 Celgene Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Celgene Recent Developments and Future Plans
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Drug Delivery in Cancer Product and Solutions
2.6.4 Sanofi Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sanofi Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Drug Delivery in Cancer Product and Solutions
2.7.4 Merck Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Merck Recent Developments and Future Plans
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Drug Delivery in Cancer Product and Solutions
2.8.4 Johnson & Johnson Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Johnson & Johnson Recent Developments and Future Plans
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Drug Delivery in Cancer Product and Solutions
2.9.4 Takeda Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Takeda Recent Developments and Future Plans
2.10 Gilead Sciences
2.10.1 Gilead Sciences Details
2.10.2 Gilead Sciences Major Business
2.10.3 Gilead Sciences Drug Delivery in Cancer Product and Solutions
2.10.4 Gilead Sciences Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Gilead Sciences Recent Developments and Future Plans
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Drug Delivery in Cancer Product and Solutions
2.11.4 Pfizer Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Pfizer Recent Developments and Future Plans
2.12 Dr Reddy
2.12.1 Dr Reddy Details
2.12.2 Dr Reddy Major Business
2.12.3 Dr Reddy Drug Delivery in Cancer Product and Solutions
2.12.4 Dr Reddy Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Dr Reddy Recent Developments and Future Plans
2.13 Samyang Biopharmaceuticals
2.13.1 Samyang Biopharmaceuticals Details
2.13.2 Samyang Biopharmaceuticals Major Business
2.13.3 Samyang Biopharmaceuticals Drug Delivery in Cancer Product and Solutions
2.13.4 Samyang Biopharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Samyang Biopharmaceuticals Recent Developments and Future Plans
2.14 Tolmar
2.14.1 Tolmar Details
2.14.2 Tolmar Major Business
2.14.3 Tolmar Drug Delivery in Cancer Product and Solutions
2.14.4 Tolmar Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Tolmar Recent Developments and Future Plans
2.15 Astellas
2.15.1 Astellas Details
2.15.2 Astellas Major Business
2.15.3 Astellas Drug Delivery in Cancer Product and Solutions
2.15.4 Astellas Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Astellas Recent Developments and Future Plans
2.16 AMAG Pharmaceuticals
2.16.1 AMAG Pharmaceuticals Details
2.16.2 AMAG Pharmaceuticals Major Business
2.16.3 AMAG Pharmaceuticals Drug Delivery in Cancer Product and Solutions
2.16.4 AMAG Pharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 AMAG Pharmaceuticals Recent Developments and Future Plans
2.17 AstraZeneca
2.17.1 AstraZeneca Details
2.17.2 AstraZeneca Major Business
2.17.3 AstraZeneca Drug Delivery in Cancer Product and Solutions
2.17.4 AstraZeneca Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 AstraZeneca Recent Developments and Future Plans
2.18 AbbVie
2.18.1 AbbVie Details
2.18.2 AbbVie Major Business
2.18.3 AbbVie Drug Delivery in Cancer Product and Solutions
2.18.4 AbbVie Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 AbbVie Recent Developments and Future Plans
2.19 Novartis
2.19.1 Novartis Details
2.19.2 Novartis Major Business
2.19.3 Novartis Drug Delivery in Cancer Product and Solutions
2.19.4 Novartis Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Novartis Recent Developments and Future Plans
2.20 Aspen
2.20.1 Aspen Details
2.20.2 Aspen Major Business
2.20.3 Aspen Drug Delivery in Cancer Product and Solutions
2.20.4 Aspen Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Aspen Recent Developments and Future Plans
2.21 Shire (Baxalta)
2.21.1 Shire (Baxalta) Details
2.21.2 Shire (Baxalta) Major Business
2.21.3 Shire (Baxalta) Drug Delivery in Cancer Product and Solutions
2.21.4 Shire (Baxalta) Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Shire (Baxalta) Recent Developments and Future Plans
2.22 Breckenridge Pharmaceuticals
2.22.1 Breckenridge Pharmaceuticals Details
2.22.2 Breckenridge Pharmaceuticals Major Business
2.22.3 Breckenridge Pharmaceuticals Drug Delivery in Cancer Product and Solutions
2.22.4 Breckenridge Pharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Breckenridge Pharmaceuticals Recent Developments and Future Plans
2.23 Galen Pharmaceuticals
2.23.1 Galen Pharmaceuticals Details
2.23.2 Galen Pharmaceuticals Major Business
2.23.3 Galen Pharmaceuticals Drug Delivery in Cancer Product and Solutions
2.23.4 Galen Pharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.23.5 Galen Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Drug Delivery in Cancer Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Drug Delivery in Cancer Players Market Share
3.2.2 Top 10 Drug Delivery in Cancer Players Market Share
3.2.3 Market Competition Trend
3.3 Drug Delivery in Cancer Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Drug Delivery in Cancer Revenue and Market Share by Type (2016-2021)
4.2 Global Drug Delivery in Cancer Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Drug Delivery in Cancer Revenue Market Share by Application (2016-2021)
5.2 Drug Delivery in Cancer Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Drug Delivery in Cancer Revenue by Type (2016-2026)
6.2 North America Drug Delivery in Cancer Revenue by Application (2016-2026)
6.3 North America Drug Delivery in Cancer Market Size by Country
6.3.1 North America Drug Delivery in Cancer Revenue by Country (2016-2026)
6.3.2 United States Drug Delivery in Cancer Market Size and Forecast (2016-2026)
6.3.3 Canada Drug Delivery in Cancer Market Size and Forecast (2016-2026)
6.3.4 Mexico Drug Delivery in Cancer Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Drug Delivery in Cancer Revenue by Type (2016-2026)
7.2 Europe Drug Delivery in Cancer Revenue by Application (2016-2026)
7.3 Europe Drug Delivery in Cancer Market Size by Country
7.3.1 Europe Drug Delivery in Cancer Revenue by Country (2016-2026)
7.3.2 Germany Drug Delivery in Cancer Market Size and Forecast (2016-2026)
7.3.3 France Drug Delivery in Cancer Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Drug Delivery in Cancer Market Size and Forecast (2016-2026)
7.3.5 Russia Drug Delivery in Cancer Market Size and Forecast (2016-2026)
7.3.6 Italy Drug Delivery in Cancer Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Drug Delivery in Cancer Revenue by Type (2016-2026)
8.2 Asia-Pacific Drug Delivery in Cancer Revenue by Application (2016-2026)
8.3 Asia-Pacific Drug Delivery in Cancer Market Size by Region
8.3.1 Asia-Pacific Drug Delivery in Cancer Revenue by Region (2016-2026)
8.3.2 China Drug Delivery in Cancer Market Size and Forecast (2016-2026)
8.3.3 Japan Drug Delivery in Cancer Market Size and Forecast (2016-2026)
8.3.4 South Korea Drug Delivery in Cancer Market Size and Forecast (2016-2026)
8.3.5 India Drug Delivery in Cancer Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Drug Delivery in Cancer Market Size and Forecast (2016-2026)
8.3.7 Australia Drug Delivery in Cancer Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Drug Delivery in Cancer Revenue by Type (2016-2026)
9.2 South America Drug Delivery in Cancer Revenue by Application (2016-2026)
9.3 South America Drug Delivery in Cancer Market Size by Country
9.3.1 South America Drug Delivery in Cancer Revenue by Country (2016-2026)
9.3.2 Brazil Drug Delivery in Cancer Market Size and Forecast (2016-2026)
9.3.3 Argentina Drug Delivery in Cancer Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Drug Delivery in Cancer Revenue by Type (2016-2026)
10.2 Middle East & Africa Drug Delivery in Cancer Revenue by Application (2016-2026)
10.3 Middle East & Africa Drug Delivery in Cancer Market Size by Country
10.3.1 Middle East & Africa Drug Delivery in Cancer Revenue by Country (2016-2026)
10.3.2 Turkey Drug Delivery in Cancer Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Drug Delivery in Cancer Market Size and Forecast (2016-2026)
10.3.4 UAE Drug Delivery in Cancer Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Drug Delivery in Cancer Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Drug Delivery in Cancer Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Drug Delivery in Cancer Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Drug Delivery in Cancer Revenue (USD Million) by Region (2016-2021)
Table 5. Global Drug Delivery in Cancer Revenue Market Share by Region (2021-2026)
Table 6. Amgen Corporate Information, Head Office, and Major Competitors
Table 7. Amgen Major Business
Table 8. Amgen Drug Delivery in Cancer Product and Solutions
Table 9. Amgen Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Teva Corporate Information, Head Office, and Major Competitors
Table 11. Teva Major Business
Table 12. Teva Drug Delivery in Cancer Product and Solutions
Table 13. Teva Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. UCB (Union Chimique Belge) Corporate Information, Head Office, and Major Competitors
Table 15. UCB (Union Chimique Belge) Major Business
Table 16. UCB (Union Chimique Belge) Drug Delivery in Cancer Product and Solutions
Table 17. UCB (Union Chimique Belge) Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Drug Delivery in Cancer Product and Solutions
Table 21. Roche Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Celgene Corporate Information, Head Office, and Major Competitors
Table 23. Celgene Major Business
Table 24. Celgene Drug Delivery in Cancer Product and Solutions
Table 25. Celgene Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sanofi Corporate Information, Head Office, and Major Competitors
Table 27. Sanofi Major Business
Table 28. Sanofi Drug Delivery in Cancer Product and Solutions
Table 29. Sanofi Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Merck Corporate Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Drug Delivery in Cancer Product and Solutions
Table 33. Merck Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 35. Johnson & Johnson Major Business
Table 36. Johnson & Johnson Drug Delivery in Cancer Product and Solutions
Table 37. Johnson & Johnson Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Takeda Corporate Information, Head Office, and Major Competitors
Table 39. Takeda Major Business
Table 40. Takeda Drug Delivery in Cancer Product and Solutions
Table 41. Takeda Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 43. Gilead Sciences Major Business
Table 44. Gilead Sciences Drug Delivery in Cancer Product and Solutions
Table 45. Gilead Sciences Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Pfizer Corporate Information, Head Office, and Major Competitors
Table 47. Pfizer Major Business
Table 48. Pfizer Drug Delivery in Cancer Product and Solutions
Table 49. Pfizer Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Dr Reddy Corporate Information, Head Office, and Major Competitors
Table 51. Dr Reddy Major Business
Table 52. Dr Reddy Drug Delivery in Cancer Product and Solutions
Table 53. Dr Reddy Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Samyang Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 55. Samyang Biopharmaceuticals Major Business
Table 56. Samyang Biopharmaceuticals Drug Delivery in Cancer Product and Solutions
Table 57. Samyang Biopharmaceuticals Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Tolmar Corporate Information, Head Office, and Major Competitors
Table 59. Tolmar Major Business
Table 60. Tolmar Drug Delivery in Cancer Product and Solutions
Table 61. Tolmar Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Astellas Corporate Information, Head Office, and Major Competitors
Table 63. Astellas Major Business
Table 64. Astellas Drug Delivery in Cancer Product and Solutions
Table 65. Astellas Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. AMAG Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 67. AMAG Pharmaceuticals Major Business
Table 68. AMAG Pharmaceuticals Drug Delivery in Cancer Product and Solutions
Table 69. AMAG Pharmaceuticals Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 71. AstraZeneca Major Business
Table 72. AstraZeneca Drug Delivery in Cancer Product and Solutions
Table 73. AstraZeneca Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. AbbVie Corporate Information, Head Office, and Major Competitors
Table 75. AbbVie Major Business
Table 76. AbbVie Drug Delivery in Cancer Product and Solutions
Table 77. AbbVie Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Novartis Corporate Information, Head Office, and Major Competitors
Table 79. Novartis Major Business
Table 80. Novartis Drug Delivery in Cancer Product and Solutions
Table 81. Novartis Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Aspen Corporate Information, Head Office, and Major Competitors
Table 83. Aspen Major Business
Table 84. Aspen Drug Delivery in Cancer Product and Solutions
Table 85. Aspen Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Shire (Baxalta) Corporate Information, Head Office, and Major Competitors
Table 87. Shire (Baxalta) Major Business
Table 88. Shire (Baxalta) Drug Delivery in Cancer Product and Solutions
Table 89. Shire (Baxalta) Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Breckenridge Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 91. Breckenridge Pharmaceuticals Major Business
Table 92. Breckenridge Pharmaceuticals Drug Delivery in Cancer Product and Solutions
Table 93. Breckenridge Pharmaceuticals Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. Galen Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 95. Galen Pharmaceuticals Major Business
Table 96. Galen Pharmaceuticals Drug Delivery in Cancer Product and Solutions
Table 97. Galen Pharmaceuticals Drug Delivery in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 98. Global Drug Delivery in Cancer Revenue (USD Million) by Players (2019-2021)
Table 99. Global Drug Delivery in Cancer Revenue Share by Players (2019-2021)
Table 100. Breakdown of Drug Delivery in Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 101. Drug Delivery in Cancer Players Head Office, Products and Services Provided
Table 102. Drug Delivery in Cancer Mergers & Acquisitions in the Past Five Years
Table 103. Drug Delivery in Cancer New Entrants and Expansion Plans
Table 104. Global Drug Delivery in Cancer Revenue (USD Million) by Type (2016-2021)
Table 105. Global Drug Delivery in Cancer Revenue Share by Type (2016-2021)
Table 106. Global Drug Delivery in Cancer Revenue Forecast by Type (2021-2026)
Table 107. Global Drug Delivery in Cancer Revenue by Application (2016-2021)
Table 108. Global Drug Delivery in Cancer Revenue Forecast by Application (2021-2026)
Table 109. North America Drug Delivery in Cancer Revenue by Type (2016-2021) & (USD Million)
Table 110. North America Drug Delivery in Cancer Revenue by Type (2021-2026) & (USD Million)
Table 111. North America Drug Delivery in Cancer Revenue by Application (2016-2021) & (USD Million)
Table 112. North America Drug Delivery in Cancer Revenue by Application (2021-2026) & (USD Million)
Table 113. North America Drug Delivery in Cancer Revenue by Country (2016-2021) & (USD Million)
Table 114. North America Drug Delivery in Cancer Revenue by Country (2021-2026) & (USD Million)
Table 115. Europe Drug Delivery in Cancer Revenue by Type (2016-2021) & (USD Million)
Table 116. Europe Drug Delivery in Cancer Revenue by Type (2021-2026) & (USD Million)
Table 117. Europe Drug Delivery in Cancer Revenue by Application (2016-2021) & (USD Million)
Table 118. Europe Drug Delivery in Cancer Revenue by Application (2021-2026) & (USD Million)
Table 119. Europe Drug Delivery in Cancer Revenue by Country (2016-2021) & (USD Million)
Table 120. Europe Drug Delivery in Cancer Revenue by Country (2021-2026) & (USD Million)
Table 121. Asia-Pacific Drug Delivery in Cancer Revenue by Type (2016-2021) & (USD Million)
Table 122. Asia-Pacific Drug Delivery in Cancer Revenue by Type (2021-2026) & (USD Million)
Table 123. Asia-Pacific Drug Delivery in Cancer Revenue by Application (2016-2021) & (USD Million)
Table 124. Asia-Pacific Drug Delivery in Cancer Revenue by Application (2021-2026) & (USD Million)
Table 125. Asia-Pacific Drug Delivery in Cancer Revenue by Region (2016-2021) & (USD Million)
Table 126. Asia-Pacific Drug Delivery in Cancer Revenue by Region (2021-2026) & (USD Million)
Table 127. South America Drug Delivery in Cancer Revenue by Type (2016-2021) & (USD Million)
Table 128. South America Drug Delivery in Cancer Revenue by Type (2021-2026) & (USD Million)
Table 129. South America Drug Delivery in Cancer Revenue by Application (2016-2021) & (USD Million)
Table 130. South America Drug Delivery in Cancer Revenue by Application (2021-2026) & (USD Million)
Table 131. South America Drug Delivery in Cancer Revenue by Country (2016-2021) & (USD Million)
Table 132. South America Drug Delivery in Cancer Revenue by Country (2021-2026) & (USD Million)
Table 133. Middle East & Africa Drug Delivery in Cancer Revenue by Type (2016-2021) & (USD Million)
Table 134. Middle East & Africa Drug Delivery in Cancer Revenue by Type (2021-2026) & (USD Million)
Table 135. Middle East & Africa Drug Delivery in Cancer Revenue by Application (2016-2021) & (USD Million)
Table 136. Middle East & Africa Drug Delivery in Cancer Revenue by Application (2021-2026) & (USD Million)
Table 137. Middle East & Africa Drug Delivery in Cancer Revenue by Country (2016-2021) & (USD Million)
Table 138. Middle East & Africa Drug Delivery in Cancer Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Drug Delivery in Cancer Picture
Figure 2. Global Drug Delivery in Cancer Revenue Market Share by Type in 2020
Figure 3. Liposomes
Figure 4. PEGylated Proteins & Polypeptides
Figure 5. Polymer Nanoparticle
Figure 6. Protein–drug Conjugates
Figure 7. Others
Figure 8. Drug Delivery in Cancer Revenue Market Share by Application in 2020
Figure 9. Hospitals & Clinic Picture
Figure 10. Cancer Treatment Centers Picture
Figure 11. Others Picture
Figure 12. Global Drug Delivery in Cancer Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Drug Delivery in Cancer Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Drug Delivery in Cancer Revenue Market Share by Region (2016-2026)
Figure 15. Global Drug Delivery in Cancer Revenue Market Share by Region in 2020
Figure 16. North America Drug Delivery in Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Drug Delivery in Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Drug Delivery in Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Drug Delivery in Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Drug Delivery in Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Drug Delivery in Cancer Market Drivers
Figure 22. Drug Delivery in Cancer Market Restraints
Figure 23. Drug Delivery in Cancer Market Trends
Figure 24. Amgen Recent Developments and Future Plans
Figure 25. Teva Recent Developments and Future Plans
Figure 26. UCB (Union Chimique Belge) Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. Celgene Recent Developments and Future Plans
Figure 29. Sanofi Recent Developments and Future Plans
Figure 30. Merck Recent Developments and Future Plans
Figure 31. Johnson & Johnson Recent Developments and Future Plans
Figure 32. Takeda Recent Developments and Future Plans
Figure 33. Gilead Sciences Recent Developments and Future Plans
Figure 34. Pfizer Recent Developments and Future Plans
Figure 35. Dr Reddy Recent Developments and Future Plans
Figure 36. Samyang Biopharmaceuticals Recent Developments and Future Plans
Figure 37. Tolmar Recent Developments and Future Plans
Figure 38. Astellas Recent Developments and Future Plans
Figure 39. AMAG Pharmaceuticals Recent Developments and Future Plans
Figure 40. AstraZeneca Recent Developments and Future Plans
Figure 41. AbbVie Recent Developments and Future Plans
Figure 42. Novartis Recent Developments and Future Plans
Figure 43. Aspen Recent Developments and Future Plans
Figure 44. Shire (Baxalta) Recent Developments and Future Plans
Figure 45. Breckenridge Pharmaceuticals Recent Developments and Future Plans
Figure 46. Galen Pharmaceuticals Recent Developments and Future Plans
Figure 47. Global Drug Delivery in Cancer Revenue Share by Players in 2020
Figure 48. Drug Delivery in Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 49. Global Top 3 Players Drug Delivery in Cancer Revenue Market Share in 2020
Figure 50. Global Top 10 Players Drug Delivery in Cancer Revenue Market Share in 2020
Figure 51. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 52. Global Drug Delivery in Cancer Revenue Share by Type in 2020
Figure 53. Global Drug Delivery in Cancer Market Share Forecast by Type (2021-2026)
Figure 54. Global Drug Delivery in Cancer Revenue Share by Application in 2020
Figure 55. Global Drug Delivery in Cancer Market Share Forecast by Application (2021-2026)
Figure 56. North America Drug Delivery in Cancer Sales Market Share by Type (2016-2026)
Figure 57. North America Drug Delivery in Cancer Sales Market Share by Application (2016-2026)
Figure 58. North America Drug Delivery in Cancer Revenue Market Share by Country (2016-2026)
Figure 59. United States Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Canada Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Mexico Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Europe Drug Delivery in Cancer Sales Market Share by Type (2016-2026)
Figure 63. Europe Drug Delivery in Cancer Sales Market Share by Application (2016-2026)
Figure 64. Europe Drug Delivery in Cancer Revenue Market Share by Country (2016-2026)
Figure 65. Germany Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. France Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. United Kingdom Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Russia Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Italy Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Asia-Pacific Drug Delivery in Cancer Sales Market Share by Type (2016-2026)
Figure 71. Asia-Pacific Drug Delivery in Cancer Sales Market Share by Application (2016-2026)
Figure 72. Asia-Pacific Drug Delivery in Cancer Revenue Market Share by Region (2016-2026)
Figure 73. China Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Japan Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Korea Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. India Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Southeast Asia Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Australia Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South America Drug Delivery in Cancer Sales Market Share by Type (2016-2026)
Figure 80. South America Drug Delivery in Cancer Sales Market Share by Application (2016-2026)
Figure 81. South America Drug Delivery in Cancer Revenue Market Share by Country (2016-2026)
Figure 82. Brazil Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Argentina Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Middle East and Africa Drug Delivery in Cancer Sales Market Share by Type (2016-2026)
Figure 85. Middle East and Africa Drug Delivery in Cancer Sales Market Share by Application (2016-2026)
Figure 86. Middle East and Africa Drug Delivery in Cancer Revenue Market Share by Country (2016-2026)
Figure 87. Turkey Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. Saudi Arabia Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. UAE Drug Delivery in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. Methodology
Figure 91. Research Process and Data Source
Buy
